Table 1.
Studies characteristics and quality. (cross-sectional study)
| Study | Published time | Country | Study design | Patients | Age | Gender(male) | AHRQ grade |
|---|---|---|---|---|---|---|---|
| Amit, M. et al. [22] | 2020 | Israel | Cross-sectional study | 156 | 72(60–82) | 108/48 | 9 |
| Bonazzetti, C et al. [14] | 2020 | Italy | Cross-sectional study | 89 | 61.5(53.1–68.7) | 69/20 | 8 |
| Fu, Guoping et al. [23] | 2020 | CHN | Cross-sectional study | 51 | 60.94 ± 14.87(25–87) | 27/14 | 8 |
| Giacobbe, D. R et al. [8] | 2020 | Italy | Cross-sectional study | 78 | 66 IQR 57–70 | 60/18 | 9 |
| Anwar, Asad et al. [26] | 2021 | UK | Cross-sectional study | 44 | 17–77 M59.5(IQR 50.5–64.5)/21–80 M59(IQR 49–67.5) | 34/10 | 8 |
| Bardi, Tommaso et al. [27] | 2021 | Spain | Cross-sectional study | 140 | 61(57–67) | 108/32 | 8 |
| d’Humières, C et al. [15] | 2021 | FRANCE | Cross-sectional study | 197 | 59(50–68) | 148/49 | 8 |
| Dupuis, Claire et al. [28] | 2021 | FRANCE | Cross-sectional study | 303 | 61(53–70) | 239/64 | 9 |
| Grasselli, G. et al. [29] | 2021 | Italy | Cross-sectional study | 774 | 62 (54–68) | 597/177 | 9 |
| Karruli, A. et al. [9] | 2021 | Italy | Cross-sectional study | 32 | 68 [55.25–75] | 23/9 | 9 |
| Kokkoris, S. et al. [30] | 2021 | Greece | Cross-sectional study | 50 | Median age 64 | 36/14 | 8 |
| Llitjos, Jean-Francois et al. [5] | 2021 | FRANCE | Cross-sectional study | 176 | 63 (55–73) | 134/42 | 8 |
| Ong, C. C. H. et al. [31] | 2021 | Singapore | Cross-sectional study | 71 | 52(39–66) | 59/12 | 9 |
| Ramos, Rafael et al. [32] | 2021 | Spain | Cross-sectional study | 213 | 61(52–71) | 110/103 | 8 |
| Roedl, Kevin et al. [33] | 2021 | Germany | Cross-sectional study | 223 | 69 (58–77.5) | 163/60 | 8 |
| Rollas, Kazim et al. [17] | 2021 | Turkey | Cross-sectional study | 38 | NR | NR | 9 |
| Søgaard, K. K et al. [34] | 2021 | Switzerland | Cross-sectional study | 41 | 64.8(54.7–72.1) | 31/10 | 9 |
| Suarez-de-la-Rica, A. et al. [35] | 2021 | Spain | Cross-sectional study | 107 | 62.2 ± 10.6 | 76/31 | 8 |
| Yakar, Mehmet Nuri et al. [36] | 2021 | Turkey | Cross-sectional study | 249 | 71(61–80) | 172/77 | 9 |
| Yao, Ren-qi et al. [6] | 2021 | CHN | Cross-sectional study | 35 | 64(59–67) | 25/10 | 8 |
| Zamora-Cintas, M. I. et al. [37] | 2021 | Spain | Cross-sectional study | 54 | NR | NR | 8 |
| Zhang, J. et al. [18] | 2021 | CHN | Cross-sectional study | 32 | 63.34 ± 12.48 | 20/12 | 9 |
| Ahlstrom, Bjorn et al. [38] | 2022 | Swedish | Cross-sectional study | 7382 | 63 (53–72) | 5191/2191 | 9 |
| Brücker, W. et al. [39] | 2022 | Germany | Cross-sectional study | 61 | 66.4 ± 13.3 | 34/27 | 9 |
| Caiazzo, L.et al. [40] | 2022 | Italy | Cross-sectional study | 89 | 68.1 ± 9.3 | 66/23 | 8 |
| Cidade, Jose Pedro et al. [41] | 2022 | Portugal | Cross-sectional study | 118 | 63.3 ± 13.1 | 87/31 | 8 |
| Ćurčić, M. et al. [42] | 2022 | Croatia | Cross-sectional study | 692 | NR | NR | 8 |
| da Costa, R. L. et al. [43] | 2022 | Brazil | Cross-sectional study | 191 | 69.66 ± 16.13 | 116/75 | 8 |
| De Bruyn, A. et al. [44] | 2022 | Belgium. | Cross-sectional study | 94 | 69.65 ± 11.29 | 55/39 | 9 |
| DeVoe, C. et al. [45] | 2022 | US | Cross-sectional study | 126 | 58.1 ± 17.9 | 85/41 | 8 |
| Erbay, Kubra et al. [11] | 2022 | Turkey | Cross-sectional study | 85 | 67.23 ± 13.05 | 54/31 | 8 |
| Kozlowski, Bartosz et al. [46] | 2022 | Poland | Cross-sectional study | 172 | 67.76 ± 11.16 | 112/60 | 8 |
| Kurt, Ahmet Furkan et al. [12] | 2022 | Turkey | Cross-sectional study | 470 | 66 ± 14.87 | 301/169 | 9 |
| Lepape, Alain et al. [47] | 2022 | FRANCE | Cross-sectional study | 4465 | 63.30 ± 11.68 | 3132/1333 | 8 |
| Mantzarlis, K. et al. [20] | 2022 | Greece | Cross-sectional study | 84 | 68.85 ± 12.17 | 56/28 | 9 |
| Mustafa, Z. U. et al. [48] | 2022 | Pakistan | Cross-sectional study | 636 | NR | 398/238 | 7 |
| Pandey, M. et al. [49] | 2022 | UK | Cross-sectional study | 299 | NR | 101/198 | 9 |
| Roda, Silvia et al. [50] | 2022 | Italy | Cross-sectional study | 22 | 61.36 ± 10.30 | 20/2 | 8 |
| Routsi, C. et al. [51] | 2022 | Greece | Cross-sectional study | 600 | NR | NR | 8 |
| Russo, A. et al. [52] | 2022 | Italy | Cross-sectional study | 32 | 62.50 ± 10.99 | 21/11 | 8 |
| Seitz, T. et al. [53] | 2022 | Austria | Cross-sectional study | 117 | 57.2 ± 11.9 | 72/45 | 8 |
| Torrecillas, Miriam et al. [7] | 2022 | Spain | Cross-sectional study | 220 | 63.65 ± 12.69 | 169/51 | 8 |
| Alenazi, T. A. et al. [54] | 2023 | Saudi Arabia | Cross-sectional study | 118 | 60.97 ± 16.32 | 74/43 | 8 |
| Alessandri, F. et al. [55] | 2023 | Italy | Cross-sectional study | 138 | 62.20 ± 15.36 | 97/41 | 9 |
| Bedenić, B. et al. [56] | 2023 | Croatia | Cross-sectional study | 118 | 71 years (range 25–94) | 78/40 | 8 |
| Bonazzetti, C. t al. [21] | 2023 | Italy | Cross-sectional study | 537 | 64.65 ± 11.15 | 402/135 | 9 |
| Guanche Garcell, H. et al. [57] | 2023 | Cuban | Cross-sectional study | 130 | NR | NR | 8 |
| Taysi, M. R. et al. [58] | 2023 | Turkey | Cross-sectional study | 205 | 68.4 ± 13.1 | 119/86 | 8 |
AHRQ Agency for Healthcare Research and Quality, NR Not reported